Publications

5674 Results

Risk-adapted low-intensity therapy in adults with Burkitt lymphoma: preliminary report of a multicenter prospective phase II study of DA-EPOCH-R

Authors
K Dunleavy;A LaCasce;B Link;S Parekh;D Jagadeesh;R Lord;P Bierman;R Mitsuyasu;R Battini;PR Watson;D Peace;BJ Averbrook;H Naina;JW Leach;W Hanna;B Powell;M Roschewski;A Lucas;SM Steinberg;B Kahl;J Friedberg;RF Little;NL Bartlett;M Fanale;WH Wilson
Journal / Conference
Blood 126(23):342; American Society of Hematology Annual Meeting (Dec 5-8, Orlando, FL), oral;
Year
2015
Research Committee(s)
Lymphoma
Study Number(s)
CTSU/9177

Genomic alterations important for the prognosis in patients with follicular lymphoma treated on SWOG Study S0016

Authors
X Qu;H Li;OW Press;L Rimsza;R Braziel;M Leblanc;E Hsi;S Smith;J Friedberg;M Fang
Journal / Conference
Blood 2015 126(23):2678; American Society of Hematology Annual Meeting (Dec 5-8, Orlando, FL), poster presentation;
Year
2015
Research Committee(s)
Lymphoma
Study Number(s)
S0016

Feasibility of interim PET-adapted therapy in HIV-positive patients with advanced Hodgkin Lymphoma (HL) – sub-analysis of SWOG S0816 phase 2 trial

Authors
A Danilov;H Li;O Press;I Shapira;L Swinnen;A Noy;E Reid;S Smith;J Friedberg
Journal / Conference
Blood 126(23):1498; American Society of Hematology Annual Meeting (Dec 5-8, Orlando, FL), poster;
Year
2015
Research Committee(s)
Lymphoma
Study Number(s)
S0816

Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer

Authors
AE Lohmann;JA Chapman;MJ Burnell;ME Levine;E Tsvetkova;K Pritchard;KA Gelmon;P O'Brien;L Han;HS Rugo;KS Albain;EA Perez;TA Vandenberg;HI Chalchal;R Sawhney;LE Shepherd;PJ Goodwin
Journal / Conference
Breast Cancer Research and Treatment Apr;150(3):605-611
Year
2015
Research Committee(s)
Breast
PMID
PMID25833209
PMC
PMC Pending

Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997

Authors
DM Lucas;AS Ruppert;G Lozanski;GW Dewald;A Lozanski;R Claus;C Plass;IW Flinn;DS Neuberg;E Paietta;JM Bennett;J Jelinek;J Gribben;M Hussein;F Appelbaum;RA Larson;DF Moore;M Tallman;JC Byrd;MR Grever
Journal / Conference
Leukemia & Lymphoma Nov;56(11):3031-3027
Year
2015
Research Committee(s)
Leukemia
PMID
PMID25721902
PMC
PMC4688910
Study Number(s)
E2997

A randomized, phase III study comparing carboplatin/paclitaxel or carboplatin/ paclitaxel/bevacizumab with or without concurrent cetuximab in patients with advanced non-small cell lung cancer (NSCLC): SWOG S0819

Authors
RS Herbst;M Redman;ES Kim;TJ Semrad;L Bazhenova;G Masters;K Oettel;P Guaglianone;C Reynolds;A Karnad;SM Arnold;M Varella-Garcia;J Moon;CD Blanke;F Hirsch;DR Gandara
Journal / Conference
Journal of Thoracic Oncology Volume 10, Number 9, Supplement 2, September 2015; World Conference on Lung Cancer (WCLC), (September 6-9, 2015, Denver, CO), oral
Year
2015
Research Committee(s)
Lung
Study Number(s)
S0819

Squamous cell lung cancer: from tumor genomics to cancer therapeutics

Authors
D Gandara;PS Hammerman;M Sos;PN Lara;F Hirsch
Journal / Conference
Clinical Cancer Research May 15;21(10):2236-2243
Year
2015
Research Committee(s)
Lung
PMID
PMID25979930
PMC
PMC4862209
Study Number(s)
S1400

Lung cancer in the era of precision medicine

Authors
K Politi;R Herbst
Journal / Conference
Clinical Cancer Research May 15;21(10):2213-2220
Year
2015
Research Committee(s)
Lung
PMID
PMID25979927
PMC
PMC4505624
Study Number(s)
S1400

EGFR tyrosine kinase inhibitors in squamous cell lung cancer

Authors
F Hirsch;R Herbst;D Gandara
Journal / Conference
Lancet Oncology Aug;16(8):872-873
Year
2015
Research Committee(s)
Lung
PMID
PMID26156654
PMC
Commentary not within scope of Public Access Policy
Study Number(s)
S1400

Patient-derived xenografts for investigation of acquired resistance in oncogene-driven cancers: building a better mousetrap

Authors
D Gandara;P Lara;P Mack
Journal / Conference
Journal of Clinical Oncology Sep 10;33(26):2839-2840
Year
2015
Research Committee(s)
Lung
PMID
PMID26215942
PMC
editorial not within scope of Public Access Policy
Study Number(s)
S1403